Duke Cancer InstituteDurham, NC
Disclosures:
1254 - Intracranial Control with Combined Dual Immune-Checkpoint Blockade and SRS for Melanoma and NSCLC Brain Metastases
Wednesday, October 4, 202312:35 PM – 12:40 PM PT